Novel Formulation of Eye Drops Containing Choline Salicylate and Hyaluronic Acid: Stability, Permeability, and Cytotoxicity Studies Using Alternative Ex Vivo and In Vitro Models
Open Access
- 26 August 2021
- journal article
- research article
- Published by MDPI AG in Pharmaceuticals
- Vol. 14 (9) , 849
Abstract
This work investigated the potential of a novel formulation of eye drops containing a non-steroidal anti-inflammatory drug—choline salicylate (CS)—and hyaluronic acid (HA). Thus, these drops may exert both anti-inflammatory and regenerative activity. The experiment was conducted through the careful characterization of physicochemical properties, stability, and quality of eye drops. Moreover, microbiological analysis, as well as penetration and cytotoxic studies, were performed. The UV, HPLC-UV, and HPLC-MS/MS methods were used to determine the purity and stability of CS. The penetration rate of CS was assessed using a hydrophilic membrane and ex vivo porcine cornea model. Additionally, the cytotoxic effects were evaluated using the SIRC cell line. The interaction between HA and CS was tested using size-exclusion chromatography and IR spectrophotometry. As a result, HA increased the viscosity of the drops, which prolonged their contact with the ocular surface, thus ensuring more effective penetration of CS into the corneal structure. After long-term storage, an interaction in the pharmaceutical phase between CS and HA was observed. However, this interaction did not affect the viability of rabbit corneal cells. Our findings showed that eye drops with CS and HA, stored at 2–8 °C in light-protected conditions, met the criteria of stability and safety.Keywords
Funding Information
- Narodowe Centrum Badań i Rozwoju (POIR.01.01.01-00-1004/18)
This publication has 45 references indexed in Scilit:
- Surface chemistry study of the interactions of hyaluronic acid and benzalkonium chloride with meibomian and corneal cell lipidsSoft Matter, 2013
- Comparative assessment of the cytotoxicity of six anti-inflammatory eyedrops in four cultured ocular surface cell lines, as determined by cell viability scoresClinical Ophthalmology, 2012
- Determination of permeability coefficients of ophthalmic drugs through different layers of porcine, rabbit and bovine eyesEuropean Journal of Pharmaceutical Sciences, 2012
- Chemical modifications of hyaluronic acid for the synthesis of derivatives for a broad range of biomedical applicationsCarbohydrate Polymers, 2011
- Cytotoxicity of prostaglandin analog eye drops preserved with benzalkonium chloride in multiple corneoconjunctival cell linesClinical Ophthalmology, 2010
- Comparative studies of various hyaluronic acids produced by microbial fermentation for potential topical ophthalmic applicationsJournal of Biomedical Materials Research Part A, 2009
- Neutral red uptake assay for the estimation of cell viability/cytotoxicityNature Protocols, 2008
- Development of the short time exposure (STE) test: An in vitro eye irritation test using SIRC cellsToxicology in Vitro, 2008
- Fluoroquinolone Eye Drop–Induced Cytotoxicity: Role of Preservative in P2X7 Cell Death Receptor Activation and ApoptosisInvestigative Ophthalmology & Visual Science, 2006
- Limiting viscosity number and weight average molecular weight of hyaluronate samples produced by heat degradationInternational Journal of Biological Macromolecules, 1988